Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein

Leukemia Research

Volumn 34, Issue 6, 2010, Pages 763-768

  Zhang, Jing ^a   Yamada, Osamu ^a   Matsushita, Yoshihisa ^a   Chagan Yasutan, Haorile ^b   Hattori, Toshio ^b  

^a Fuso Pharmaceutical Industries Ltd   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AP 1; HTLV 1; Osteopontin; PI3K AKT; Tax; Transactivation

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TAX PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMOGENESIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TRANSACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BASE SEQUENCE; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LIVER NEOPLASMS; OSTEOPONTIN; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 77952094196     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.08.028     Document Type: Article

References (50)

1. Yoshida M., Seiki M., Yamaguchi K., Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984, 81:2534.
2. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., et al. The antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407.
3. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986, 1:1031.
4. Nerenberg M., Hinrichs S.H., Reynolds R.K., Khoury G., Jay G. A transgenic mouse model for human neurofibromatosis. Science 1987, 237:1324.
5. Pozzatti R., Vogel J., Jay G. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol Cell Biol 1990, 10:413.
6. Grassmann R., Fleckenstein B., Desrosiers R.C. Viral transformation of human T lymphocytes. Adv Cancer Res 1994, 63:211.
7. Matsuoka M., Jeang K.T. Human T-cell leukemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007, 7:270.
8. Neuveut C., Jeang K.T. Cell cycle dysregulation by HTLV-I: role of the tax oncoprotein. Front Biosci 2002, 7:d157.
9. Boxus M., Twizere J.C., Legros S., Dewulf J.F., Kettmann R., et al. The HTLV-1 Tax interactome. Retrovirology 2008, 5:76.
10. Jeong S.J., Pise-Masison C.A., Radonovich M.F., Park H.U., Brady J.N. Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 2005, 24:6719.
11. Jeong S.J., Dasgupta A., Jung K.J., Um J.H., Burke A., et al. PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1 transformed cells. Virology 2008, 370:264.
12. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 1998, 95:11211.
13. Brazil D.P., Park J., Hemmings B.A. PKB binding proteins. Getting in on the Akt. Cell 2002, 111:293.
14. Song G., Ouyang G., Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005, 9:59.
15. Peloponese J.M., Jeang K.T. Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J Biol Chem 2006, 281:8927.
16. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000, 287:860.
17. Tuck A.B., Arsenault D.M., O'Malley F.P., Hota C., Ling M.C., et al. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Oncogene 1999, 18:4237.
18. Tuck A.B., Elliott B.E., Hota C., Tremblay E., Chambers A.F. Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). J Cell Biochem 2000, 78:465.
19. Lin Y.H., Yang-Yen H.F. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J Biol Chem 2001, 276:46024.
20. Philip S., Bulbule A., Kundu G.C. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem 2001, 276:44926v.
21. Hirama M., Takahashi F., Takahashi K., Akutagawa S., Shimizu K., et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth. Cancer Lett 2003, 198:107.
22. Leali D., Dell'Era P., Stabile H., Sennino B., Chambers A.F., et al. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J Immunol 2003, 171:1085.
23. Patani N., Jouhra F., Jiang W., Mokbel K. Osteopontin expression profiles predict pathological and clinical outcome in breast cancer. Anticancer Res 2008, 28:4105.
24. Craig A.M., Denhardt D.T. The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene 1991, 100:163.
25. Craig A.M., Smith J.H., Denhardt D.T. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J Biol Chem 1989, 264:9682.
26. Noda M., Vogel R.L., Craig A.M., Prahl J., DeLuca H.F., et al. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 1990, 87:9995.
27. Hijiya N., Setoguchi M., Matsuura K., Higuchi Y., Akizuki S., et al. Cloning and characterization of the human osteopontin gene and its promoter. Biochem J 1994, 303:255.
28. Blobel G.A., Hanafusa H. The v-src inducible gene 9E3/pCEF4 is regulated by both its promoter upstream sequence and its 3′ untranslated region. Proc Natl Acad Sci USA 1991, 88:1162.
29. Wang D., Yamamoto S., Hijiya N., Benveniste E.N., Gladson C.L. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interaction. Oncogene 2000, 19:5801.
30. Yamaoka S., Inoue H., Sakurai M., Sugiyama T., Hazama M., et al. Constitutive activation of NF-kB is essential for transformation of rat ribroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J 1996, 15:873.
31. Zhang J., Yamada O., Kawagishi K., Yoshida H., Araki H., et al. Up-regulation of hepatitis C virus replication by human T cell leukemia virus type I-encoded Tax protein. Virology 2007, 369:198.
32. Zhang J., Yamada O., Sakamoto T., Yoshida H., Iwai T., et al. Down-regulation of viral replication by adenviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus. Virology 2004, 320:135.
33. Rousset R., Fabre S., Desbois C., Bantignies F., Jalinot P. The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Oncogene 1998, 16:643.
34. Suzuki T., Ohsugi Y., Uchida-Toita M., Akiyama T., Yoshida M. Tax oncoprotein of HTLV-1 binds to the human homologue of Drosophila discs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control. Oncogene 1999, 18:5967.
35. Ishioka K., Higuchi M., Takahashi M., Yoshida S., Oie M., et al. Inactivation of tumor suppressor Dlg1 augments transformation of a T-cell line induced by human T-cell leukemia virus type I Tax. Retrovirology 2006, 3:71.
36. Frese K.K., Lee S.S., Thomas D.L., Latorre I.J., Weiss R.S., et al. Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenvirus E4-ORF1 oncoprotein. Oncogene 2003, 22:710.
37. Zhang G., He B., Weber G.F. Growth factor signaling induces metastasis genes in transformed cells: molecular connection between AKT kinase and osteopontin in breast cancer. Mol Cell Biol 2003, 23:6507.
38. Whalen K.A., Weber G.F., Benjamin T.L., Schaffhausen B.S. Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells. J Virol 2008, 82:4946.
39. Fukuda R.I., Tsuchiya K., Suzuki K., Itoh K., Fujita J., et al. Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-kappaB pathway. J Biol Chem 2009, 284:2680.
40. Irita J., Okura T., Kurata M., Miyoshi K., Fukuoka T. Osteopontin in rat renal fibroblasts: functional properties and transcriptional regulation by aldosterone. Hypertension 2008, 51:507.
41. Kim H.J., Lee M.H., Kim H.J., Shin H.I., Choi J.Y., et al. Okadaic acid stimulates osteopontin expression through de novo induction of AP-1. J Cell Biochem 2002, 87:93.
42. Ng P.W., Iha H., Iwanaga Y., Bittner M., Chen Y., et al. Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation. Oncogene 2001, 20:4484.
43. Jeang K.T., Chiu R., Santos E., Kim S.J. Induction of the HTLV-I LTR by Jun occurs through the Tax-responsive 21-bp elements. Virology 1991, 181:218.
44. Gao L., Deng H., Zhao H., Hirbe A., Harding J., et al. HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition. Blood 2005, 106:4294.
45. Nadella M.V., Shu S.T., Dirksen W.P., Thudi N.K., Nadella K.S., et al. Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-I: implication for transformation. Retrovirology 2008, 5:46.
46. Miyauchi A., Alvarez J., Greenfield E.M., Teti A., Grano M., et al. Recognition of osteopontin and related peptides by αvβ3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 1991, 266:20369.
47. Gao C., Guo H., Downey L., Marroquin C., Wei J., et al. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells. Carcinogenesis 2003, 24:1871.
48. Marroquin C.E., Downey L., Guo H., Kuo P.C. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells. Immunol Lett 2004, 95:109.
49. Khan S.A., Cook A.C., Kappil M., Gunthert U., Chambers A.F., et al. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clin Exp Metastasis 2005, 22:663.
50. Matsuoka E., Usuku K., Jonosono M., Takenouchi N., Izumo S., et al. CD44 splice variant involvement in the chronic inflammatory disease of the spinal cord: HAM/TSP. J Neuroimmunol 2000, 102:1.